Mycotoxin Testing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Mycotoxin Testing Market Report is Segmented by Technology Type (Chromatography-Based, Immunoassay-Based, Rapid Test Kits, Spectroscopy and Biosensor-Based, and Other Technologies), Mycotoxin Type (Aflatoxins, Ochratoxin A, Patulin, Fusarium Toxins, and Other Mycotoxins), Tested Commodity (Food, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Mycotoxin Testing Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Mycotoxin Testing Market with other markets in Food & Beverage Industry

Mycotoxin Testing Market Analysis by Mordor Intelligence

The global mycotoxin testing market is expected to reach a size of USD 2.13 billion in 2025 and is projected to expand to USD 3.08 billion by 2030, at a CAGR of 7.67% during the forecast period. This growth trajectory reflects the escalating regulatory pressure following high-profile contamination incidents, including France's rejection of Turkish dried figs due to aflatoxin levels exceeding legal limits by 20 times in December 2024 and the tragic death of 450 dogs in Malawi from aflatoxin-contaminated maize. Chromatography-based platforms remain the benchmark for confirmatory analysis, yet rapid test kits are gaining ground as processors seek point-of-use screening. Climate-linked shifts in fungal prevalence, such as the surge in Fusarium toxins, further underpin routine testing demand. Global laboratories scale capacity in response to the European Union’s Regulation 2023/915 and the United States’ LAAF mandates, while Asia-Pacific laboratories add accredited instrumentation to serve rising export volumes according to FDA (Food and Drug Administration [1]Source: European Union,"Commission Regulation (EU)", eur-lex.europa.eu.

Key Report Takeaways

By technology type, the chromatography-based segment led with 37.34% revenue share in 2024; rapid test kits are forecast to expand at a 9.12% CAGR through 2030.

By mycotoxin type, aflatoxins accounted for 30.13% of the mycotoxin testing market share in 2024, while Fusarium toxins are projected to grow at 9.56% CAGR through 2030.

By tested commodity, the food segment held 82.47% share of the mycotoxin testing market size in 2024, whereas pet food and animal feed testing are set to rise at an 8.89% CAGR between 2025-2030.

By geography, North America contributed 34.89% revenue share in 2024 and Asia-Pacific is forecast to advance at a 9.45% CAGR through 2030. 

Segment Analysis

By Technology Type: Rapid Innovation Drives Market Evolution

In 2024, chromatography-based technologies held a commanding 37.34% market share, bolstered by regulatory mandates for confirmatory analyses and the heightened precision required for trace-level detections. Meanwhile, rapid test kits emerged as the industry's fastest-growing segment, boasting a 9.12% CAGR projected through 2030, underscoring a pronounced shift towards point-of-use testing. Waters Corporation's launch of the waters_connect Data Intelligence software in November 2024 highlights the industry's pivot, steering chromatographic platforms towards cloud-centric business intelligence and heightened audit readiness. While immunoassay methods remain the go-to for primary screenings, there's a noticeable uptick in the adoption of spectroscopy and biosensor methods for real-time monitoring.

Artificial intelligence's integration with conventional analytical techniques is carving out a competitive edge. Notably, machine learning algorithms are refining hyperspectral imaging's accuracy for mycotoxin detection in cereal grains, as highlighted by MDPI (Multidisciplinary Digital Publishing Institute). Innovations in nanotechnology and microfluidics are propelling the momentum of other technologies, such as novel biosensor platforms and portable detection devices. Furthermore, advancements like time-resolved fluorescence immunoassays, which now detect aflatoxin B1 at an impressive 0.3 µg/kg limit, underscore the industry's relentless pursuit of heightened sensitivity across all platforms.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Mycotoxin Type: Fusarium Toxins Emerge as Growth Driver

In 2024, aflatoxins held a dominant 30.13% share of the market, underscoring their position as the world's most stringently regulated mycotoxin class. Meanwhile, Fusarium toxins emerged as the fastest-growing category, boasting a 9.56% CAGR projected through 2030. The European Union's introduction of binding limits for T-2 and HT-2 toxins, set to take effect in July 2024, has spurred a surge in testing demand for these compounds, which were previously not as closely monitored. Testing for Ochratoxin A remains consistently in demand, largely due to the needs of the wine and coffee sectors, whereas patulin testing is predominantly centered on fruit products.

Advancements in multi-mycotoxin detection platforms have revolutionized the economics of testing. For instance, lateral flow immunoassays can now simultaneously detect aflatoxin B1, zearalenone, and T-2 toxin in just 20 minutes, as reported by MDPI (Multidisciplinary Digital Publishing Institute). A tragic reminder of the dangers posed by aflatoxins is the incident in Malawi, where 450 dogs lost their lives due to aflatoxin-contaminated maize. On a proactive note, Spectral Blue has pioneered a Multi-Wavelength, High-Intensity blue light technology, aiming to diminish deoxynivalenol levels in tainted grains, marking a significant stride in post-harvest mycotoxin management.

By Tested Commodity: Pet Food Segment Accelerates

In 2024, the food segment dominated the market with an 82.47% share, covering categories like meat, poultry, dairy, fruits, vegetables, and processed foods. However, the pet food and animal feed testing segment is emerging as the fastest-growing, boasting an 8.89% CAGR projected through 2030. A notable driver of this growth is Taiwan's July 2024 move to set safety tolerance levels for five additional mycotoxins in pet food. This includes specific limits for vomitoxin and fumonisin. Within the broader food category, testing has intensified: processed food scrutiny heightened after contamination incidents, dairy testing zeroes in on aflatoxin M1, and fruits and vegetables testing targets patulin and other mycotoxins.

Advanced optical sorting technologies are reshaping pet food safety. Bühler's SORTEX LumoVision, for instance, can slash aflatoxin levels by up to 90% using fluorescence to detect contaminated kernels. As regulatory frameworks broaden, there's a surge in testing demands for other food categories, notably specialty products and nutraceuticals. The FDA's post-October 2024 enforcement policy for AAFCO-defined animal feed ingredients has set clear regulatory expectations for novel feed components, all while upholding stringent safety standards.

Mycotoxin Testing Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

In 2024, North America secured a commanding lead with a 34.89% market share, thanks to stringent FDA enforcement and a robust testing infrastructure. The Asia-Pacific region, however, is making waves, projecting a notable 9.45% CAGR through 2030. Demonstrating its dedication, the FDA has set aside USD 15 million in its FY 2025 budget, zeroing in on microbiological and chemical safety. Europe benefits from harmonized regulations under EU Regulation 2023/915, yet Brexit has complicated trade dynamics between the UK and the EU.

In South America, key grain-producing regions are battling climate-induced contamination issues. Concurrently, the Middle East and Africa are bolstering their testing infrastructures to meet export standards. Japan's swift action on mold detection, following several contamination incidents in 2024-2025, underscores the region's dedication to food safety. India's FSSAI has extended foreign facility registration requirements to September 2024, signaling the shifting regulatory landscape in emerging markets.

Canada's 2024-2025 departmental plan prioritizes regulatory modernization and boosts laboratory capacity for disease detection, reinforcing the region's testing infrastructure. Meanwhile, the European Environment Agency warns of mycotoxin exposure due to shifting climate conditions, stressing the urgency for adaptive testing strategies.

Mycotoxin Testing Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all Individual segments will be available upon report purchase

Competitive Landscape

The mycotoxin testing market is moderately fragmented, marked by fierce competition among established laboratory service providers and manufacturers of analytical instruments. Some of the major players include DSM-Firmenich, Eurofins Scientific, and SGS Société Générale de Surveillance SA, among others. A notable instance of strategic consolidation is Mérieux NutriSciences' acquisition of Bureau Veritas' food testing business for EUR 360 million in October 2024. This move has birthed a unified entity boasting 34 laboratories worldwide and a workforce exceeding 1,900.

Companies are heavily investing in AI-driven analytical solutions and cloud-based data management systems, focusing on technology differentiation through automation capabilities, multi-analyte detection platforms, and seamless integration with digital infrastructure. Eurofins Scientific's revenue surged by 6.7% in the first three quarters of 2024, hitting EUR 5,142 million, underscoring the market's significant growth potential. Patent filings are predominantly centered on enhancing analytical methods and innovating detection technologies, with a notable emphasis on novel biosensor designs and advanced sample preparation techniques.

New entrants, particularly specialized biosensor developers and manufacturers of rapid testing kits, are redefining the landscape, offering point-of-use solutions that rival traditional laboratory models. While technology frontrunners harness proprietary analytical methods and navigate regulatory landscapes for a competitive edge, smaller entities carve out niches in specific applications or regional markets. The FDA's Laboratory Flexible Funding Model Cooperative Agreement Program, with its allocation of USD 23.2 million aimed at bolstering state laboratory capabilities, paves the way for collaborative ventures between public entities and private firms in advancing testing infrastructure.

Mycotoxin Testing Industry Leaders

  1. DSM-Firmenich

  2. Eurofins Scientific

  3. SGS Société Générale de Surveillance SA.

  4. Institut Mérieux

  5. Thermo Fisher Scientific Inc. 

  6. *Disclaimer: Major Players sorted in no particular order
Mycotoxin Testing Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • June 2025: Thermo Fisher Scientific unveiled next-generation Orbitrap Astral Zoom and Orbitrap Excedion Pro mass spectrometers at ASMS 2025, offering 35% faster scan speeds and 40% higher throughput for enhanced proteomics and biopharmaceutical applications.
  • February 2025: Mérieux NutriSciences completed acquisition of Bureau Veritas' worldwide food testing business for EUR 360 million, expanding operations to 32 countries and doubling presence in Canada and Asia-Pacific.
  • July 2024: Taiwan introduced safety tolerance levels for 5 additional mycotoxins in pet food, including vomitoxin, fumonisin, zearalenone, ochratoxin, and T-2 mycotoxin, enhancing pet food safety standards.
  • July 2024: SGS North America announced expansion of biologics testing capabilities at Lincolnshire Center of Excellence, adding new instrumentation and scientific expertise for biopharmaceutical market.

Table of Contents for Mycotoxin Testing Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing awareness among consumers about food safety
    • 4.2.2 Stringent food safety regulations
    • 4.2.3 Increased contamination incidents in grains, nuts, and processed foods
    • 4.2.4 Advancements in testing technologies
    • 4.2.5 Expansion of certified testing laboratories in emerging markets
    • 4.2.6 Increased adoption of rapid testing kits
  • 4.3 Market Restraints
    • 4.3.1 High cost of advanced testing equipment and reagents
    • 4.3.2 Lack of standardized testing regulations
    • 4.3.3 Limited access to accredited labs in developing regions
    • 4.3.4 Shortage of skilled technicians for handling complex instruments
  • 4.4 Supply Chain Analysis
  • 4.5 Regulatory Outlook
  • 4.6 Porter’s Five Forces
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Technology Type
    • 5.1.1 Chromatography-based
    • 5.1.2 Immunoassay-based
    • 5.1.3 Rapid Test Kits
    • 5.1.4 Spectroscopy and Biosensor-based
    • 5.1.5 Other Technologies
  • 5.2 By Mycotoxin Type
    • 5.2.1 Aflatoxins
    • 5.2.2 Ochratoxin A
    • 5.2.3 Patulin
    • 5.2.4 Fusarium Toxins
    • 5.2.5 Other Mycotoxins
  • 5.3 By Tested Commodity
    • 5.3.1 Food
    • 5.3.1.1 Meat and Poultry
    • 5.3.1.2 Dairy
    • 5.3.1.3 Fruits and Vegetables
    • 5.3.1.4 Processed Food
    • 5.3.1.5 Other Food
    • 5.3.2 Pet Food and Animal Feed
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
    • 5.4.2.1 United Kingdom
    • 5.4.2.2 Germany
    • 5.4.2.3 Spain
    • 5.4.2.4 France
    • 5.4.2.5 Italy
    • 5.4.2.6 Russia
    • 5.4.2.7 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 Australia
    • 5.4.3.5 Rest of Asia Pacific
    • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
    • 5.4.5.1 Saudi Arabia
    • 5.4.5.2 South Africa
    • 5.4.5.3 Rest of Middle East and Africa

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Ranking Analysis
  • 6.4 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials (if available), Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
    • 6.4.1 Eurofins Scientific
    • 6.4.2 SGS Société Générale de Surveillance SA.
    • 6.4.3 SCIEX
    • 6.4.4 ALS Limited
    • 6.4.5 Symbio Labs.
    • 6.4.6 Neogen Corporation
    • 6.4.7 DSM-Firmenich
    • 6.4.8 Institut Mérieux
    • 6.4.9 TUV SÜD
    • 6.4.10 Fera Science Limited (“Fera”).
    • 6.4.11 Charm Sciences
    • 6.4.12 Thermo Fisher Scientific Inc.
    • 6.4.13 Agilent Technologies, Inc.
    • 6.4.14 Waters Corporation
    • 6.4.15 Microbac Laboratories, Inc.
    • 6.4.16 Shimadzu Corporation
    • 6.4.17 Randox Laboratories
    • 6.4.18 Waters Corporation (VICAM)
    • 6.4.19 Bio-Rad Laboratories, Inc.
    • 6.4.20 Bruker

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Mycotoxin Testing Market Report Scope

The global mycotoxin testing market is segmented by technology into HPLC-based, LC-MS/MS-based, Immunoassay-based, and Other Technologies. By pathogen type into Aflatoxins, Ochratoxin A, Patulin, Fusarium Toxins, Other Mycotoxins. By application into beverages and foods. By geography, the scope includes North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

By Technology Type Chromatography-based
Immunoassay-based
Rapid Test Kits
Spectroscopy and Biosensor-based
Other Technologies
By Mycotoxin Type Aflatoxins
Ochratoxin A
Patulin
Fusarium Toxins
Other Mycotoxins
By Tested Commodity Food Meat and Poultry
Dairy
Fruits and Vegetables
Processed Food
Other Food
Pet Food and Animal Feed
By Geography North America United States
Canada
Mexico
Rest of North America
Europe United Kingdom
Germany
Spain
France
Italy
Russia
Rest of Europe
Asia-Pacific China
India
Japan
Australia
Rest of Asia Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa Saudi Arabia
South Africa
Rest of Middle East and Africa
By Technology Type
Chromatography-based
Immunoassay-based
Rapid Test Kits
Spectroscopy and Biosensor-based
Other Technologies
By Mycotoxin Type
Aflatoxins
Ochratoxin A
Patulin
Fusarium Toxins
Other Mycotoxins
By Tested Commodity
Food Meat and Poultry
Dairy
Fruits and Vegetables
Processed Food
Other Food
Pet Food and Animal Feed
By Geography
North America United States
Canada
Mexico
Rest of North America
Europe United Kingdom
Germany
Spain
France
Italy
Russia
Rest of Europe
Asia-Pacific China
India
Japan
Australia
Rest of Asia Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa Saudi Arabia
South Africa
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current size of the mycotoxin testing market?

The market is valued at USD 2,132 million in 2025 and is forecast to reach USD 3,085.52 million by 2030.

Which testing technology holds the largest share?

Chromatography platforms lead with 37.34% revenue share in 2024, reflecting their role in confirmatory analysis.

Why are Fusarium toxins attracting more attention?

Climate shifts have raised Fusarium contamination levels, and new EU limits introduced in 2024 mandate greater surveillance.

Which region is growing the fastest?

Asia-Pacific is projected to register a 9.45% CAGR through 2030, driven by expanding export-oriented testing capacity.

How will rapid test kits impact the future landscape?

Rapid kits are set to grow at 9.12% CAGR, enabling on-site screening and faster release of shipments without sacrificing accuracy.

Mycotoxin Testing Market Report Snapshots